We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.
- Authors
Hirt, Penelope; Park, Lily; Wallace, Carly E.; Kerdel, Francisco
- Abstract
Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine.
- Subjects
SWEET'S syndrome; COVID-19 vaccines; BOOSTER vaccines; SARS-CoV-2; CELLULITIS; VACCINATION
- Publication
Dermatology Reports, 2023, Vol 15, Issue 3, p1
- ISSN
2036-7406
- Publication type
Case Study
- DOI
10.4081/dr.2023.9668